Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd.
Petition for certiorari denied on October 3, 2022
Issues: (1) Whether, despite the Supreme Court’s “well established”
interpretation of the Sherman Act, U.S. courts may
reinterpret the same text of that act case by case
using a discretionary 10-factor balancing test under
the doctrine of prescriptive comity; and (2) whether a court interpreting the meaning of
foreign law under Federal Rule of Civil Procedure 44.1
is limited to the “face” of written legal materials, as
the decision below held, or may also consider evidence
as to how foreign law is implemented and enforced
that would be relevant to the interpretive inquiry in
the foreign legal system.
Date | Proceedings and Orders (key to color coding) |
---|
Dec 13 2021 | Application (21A227) to extend the time to file a petition for a writ of certiorari from January 19, 2022 to March 20, 2022, submitted to Justice Sotomayor. |
Dec 16 2021 | Application (21A227) granted by Justice Sotomayor extending the time to file until March 21, 2022. |
Mar 21 2022 | Petition for a writ of certiorari filed. (Response due April 22, 2022) |
Apr 11 2022 | Brief amici curiae of Professors William S. Dodge and Paul B. Stephan filed. |
Apr 12 2022 | Motion to extend the time to file a response from April 22, 2022 to June 21, 2022, submitted to The Clerk. |
Apr 13 2022 | Motion to extend the time to file a response is granted and the time is extended to and including June 21, 2022. |
Apr 22 2022 | Brief amicus curiae of Chamber of Commerce of the United States filed. |
Jun 21 2022 | Brief of respondents Hebei Welcome Pharmaceutical Co. Ltd., et al. in opposition filed. |
Jul 06 2022 | DISTRIBUTED for Conference of 9/28/2022. |
Jul 06 2022 | Reply of petitioners Animal Science Products Inc., et al. filed. (Distributed) |
Oct 03 2022 | Petition DENIED. |